Final - July 21, 2021 MEETING OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP) Centers for Disease Control and Prevention Atlanta, Georgia 30329 July 22, 2021 AGENDA ITEM PRESIDER/PRESENTER(s) Thursday, July 22, 2021 11:00 Welcome & Introductions Dr. José Romero (ACIP Chair) Dr. Amanda Cohn (ACIP Executive Secretary, CDC) 11:30 Coronavirus Disease 2019 (COVID-19) Vaccines Introduction Dr. Matthew Daley (ACIP, WG Chair) Guillain-Barré Syndrome (GBS) after Janssen COVID-19 vaccine: Dr. Meghna Alimchandani (FDA) Vaccine Adverse Event Reporting System (VAERS) Guillain-Barré Syndrome (GBS) after Janssen COVID-19 vaccine: Dr. Nicola Klein (Kaiser Permanente Northern California) Vaccine Safety Datalink (VSD) VaST assessment of GBS after Janssen COVID-19 vaccine Dr. Grace Lee (ACIP, VaST Chair) Discussion 1:00 Break 1:15 Public comment 1:45 COVID-19 vaccines: benefits-risk discussion Dr. Hannah Rosenblum (CDC/NCIRD) Work Group interpretation and next steps Dr. Sarah Mbaeyi (CDC/NCIRD) Discussion 3:15 Break 3:30 Data and clinical considerations for additional doses in immunocompromised Dr. Sara Oliver (CDC/NCIRD) 4:30 Adjourn Acronyms CDC Centers for Disease Control and Prevention CMS Centers for Medicare and Medicaid Services COVID-19 Coronavirus Disease 2019 EtR Evidence to Recommendations Framework FDA Food and Drug Administration GRADE Grading of Recommendations Assessment, Development and Evaluation HRSA Health Resources and Services Administration IHS Indian Health Service NCHHSTP National Center for HIV, Hepatitis, STD and TB Prevention [of CDC/DDID] NCIRD National Center for Immunization & Respiratory Diseases [of CDC/DDID] NCEZID National Center for Emerging and Zoonotic Diseases [of CDC/DDID] NIAID National Institute of Allergy and Infectious Diseases page 1 of 1.